Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;20(1):68-72.
doi: 10.3892/etm.2020.8474. Epub 2020 Jan 27.

Acquired angioedema induced by angiotensin-converting enzyme inhibitors - experience of a hospital-based allergy center

Affiliations

Acquired angioedema induced by angiotensin-converting enzyme inhibitors - experience of a hospital-based allergy center

Polliana Mihaela Leru et al. Exp Ther Med. 2020 Jul.

Abstract

Angiotensin-converting enzyme inhibitors (ACEIs) represent an important group of pharmacological compounds, largely prescribed for more than 30 years. They have been extensively evaluated in clinical trials, demonstrating significant reduction of morbidity and mortality of patients with cardiovascular diseases, mainly high blood pressure, myocardial infarction, heart failure and stroke. Besides their beneficial effects and a general good safety profile, it was proven that ACEIs might also induce adverse effects in some patients, most notably angioedema (AE) and chronic cough. The occurrence rate of adverse events induced by ACEIs is low, but the number of suffering patients is relatively high, since ACEIs is one of the most frequently prescribed medication worldwide. The aim of our study was to evaluate clinical pattern, risk factors and general management of ACEI-induced angioedema in a cohort of patients addressed for allergist evaluation in one university hospital in Romania, during a period of 32 months. It was found that ACEI-induced angioedema (ACEI-AE) represented more than half of the total number of patients addressed for angioedema without urticaria, with variable clinical and time-patterns. Most of the patients were referred by general practitioners (GPs) with diagnosis of urticaria or other skin allergy and continued to take ACEIs for months and years after onset of angioedema. We concluded that the awareness of acquired, non-allergic angioedema induced by ACEI therapy in medical practice is still low and there is a need for improved knowledge and interdisciplinary collaboration in this field.

Keywords: acquired angioedema; allergy center; angiotensin-converting enzyme inhibitors; safety profile.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pharmacological substances from ACEIs class used by the study group (number of patients for each substance). ACEIs, angiotensin-converting enzyme inhibitors.
Figure 2
Figure 2
Duration of treatment with ACEIs (number of patients for each time period). ACEIs, angiotensin-converting enzyme inhibitors.
Figure 3
Figure 3
Angioedema localization (number of patients for each site).

References

    1. Smith RE, Ashiya M. Antihypertensive therapies. Nat Rev Drug Discov. 2007;6:597–598. doi: 10.1038/nrd2354. - DOI - PubMed
    1. Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation. 2006;113:213–221. doi: 10.1161/CIRCULATIONAHA.105.542290. - DOI - PubMed
    1. Dunlap ME, Peterson RC. ACE inhibitors vs ARBs: Is one class better for heart failure. Cleve Clin J Med. 2002;69:433–438. doi: 10.3949/ccjm.69.5.433. - DOI - PubMed
    1. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: Outcome after switching to a different treatment. Arch Intern Med. 2004;164:910–913. doi: 10.1001/archinte.164.8.910. - DOI - PubMed
    1. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100:327–332. doi: 10.1016/S1081-1206(10)60594-7. - DOI - PubMed